EuroCarbDB
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • (408) 472-2934
  • Sign in
  • Contact Us
EuroCarbDB
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • (408) 472-2934
  • Sign in
  • Contact Us
  1. Products
  2. E. coli Recombinant
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

E. coli Recombinant

[0544-MBS960136] CSDA E. coli Rec. protein :: DNA-binding protein A (CSDA) E. coli Rec. Protein - 0.02 mG. (Baculovirus)
CSDA E. coli Rec. protein :: DNA-binding protein A (CSDA) E. coli Rec. Protein - 0.02 mG. (Baculovirus)
1,788.00 € 1788.0 EUR
[0544-MBS355892-1mG.] COVID-19 E. coli Rec. protein :: COVID 19 Nucleocapsid (NP) Coronavirus E. coli Rec. Protein - 1mG.
COVID-19 E. coli Rec. protein :: COVID 19 Nucleocapsid (NP) Coronavirus E. coli Rec. Protein - 1mG.
814.00 € 814.0 EUR
[0544-MBS355894-1mG.] COVID 19 Nucleocapsid (NP) Coronavirus E. coli Rec. Protein - 1mG.
COVID 19 Nucleocapsid (NP) Coronavirus E. coli Rec. Protein - 1mG.
814.00 € 814.0 EUR
[0544-MBS2009059-0.1mG.] COL6a1 E. coli Rec. protein :: Collagen Type VI Alpha 1 (COL6a1) E. coli Rec. Protein 0.1mG.
COL6a1 E. coli Rec. protein :: Collagen Type VI Alpha 1 (COL6a1) E. coli Rec. Protein 0.1mG.
642.30 € 642.3000000000001 EUR
[0544-MBS2545190-0.1mG.] COL6A3 E. coli Rec. protein :: COL6A3 / Collagen-VI E. coli Rec. Protein 0.1mG.
COL6A3 E. coli Rec. protein :: COL6A3 / Collagen-VI E. coli Rec. Protein 0.1mG.
1,067.50 € 1067.5 EUR
[0544-MBS7609400-0.2mG.] COL6A2 E. coli Rec. protein :: Collagen VI alpha 2 E. coli Rec. Protein 0.2mG.
COL6A2 E. coli Rec. protein :: Collagen VI alpha 2 E. coli Rec. Protein 0.2mG.
1,024.30 € 1024.3 EUR
[0544-MBS958486-0.1mG.(Yeast)] CD81 E. coli Rec. protein :: CD81 antigen (CD81) E. coli Rec. Protein, 0.1mG. (Yeast)
CD81 E. coli Rec. protein :: CD81 antigen (CD81) E. coli Rec. Protein, 0.1mG. (Yeast)
759.00 € 759.0 EUR
[0247-OPCD01948-50] CCDC80 E. coli Rec. Protein - 50 ug.
CCDC80 E. coli Rec. Protein - 50 ug.
564.00 € 564.0 EUR
[0247-OPCD01948-200] CCDC80 E. coli Rec. Protein - 200 ug.
CCDC80 E. coli Rec. Protein - 200 ug.
917.00 € 917.0 EUR
[0247-OPCD01948-10] CCDC80 E. coli Rec. Protein - 10ug.
CCDC80 E. coli Rec. Protein - 10ug.
343.00 € 343.0 EUR
[0975-KMP1935-100ug.] Biotinylated E. coli Rec. Human CD79B Protein - 100 ug.
Biotinylated E. coli Rec. Human CD79B Protein - 100 ug.
1,500.00 € 1500.0 EUR
[0544-MBS1217721-EC-0.1mG.] Beta-lactamase OXA-10 (bla), E. coli Rec. Protein 0.1mG. (E.coli)
Beta-lactamase OXA-10 (bla), E. coli Rec. Protein 0.1mG. (E.coli)
992.00 € 992.0 EUR
[0708-TAB-718LC-1mG.] Anti-human Integrin α4β7 E. coli Rec. Antibody (J19), Conjug.ation: NONE, Endotoxin: Regular without removal, 1 mG.
Anti-human Integrin α4β7 E. coli Rec. Antibody (J19), Conjug.ation: NONE, Endotoxin: Regular without removal, 1 mG.
5,705.00 € 5705.0 EUR
[0708-TAB-735-PE] Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 2 mG.
Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 2 mG.
14,376.00 € 14376.0 EUR
Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 1 mG. (copy)
Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 1 mG. (copy)
8,632.00 € 8632.0 EUR
[0708-TAB-735-PE-1mG.] Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 1 mG.
Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95%, PE, 1 mG.
8,632.00 € 8632.0 EUR
[0708-TAB-735-1mG.] Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95% 1mG.
Anti-Influenza A hemagglutinin E. coli Rec. Antibody (Diridavumab (CR6261)) -Regular Batch (No Endotoxin Removal), SDS-PAGE>95% 1mG.
6,848.00 € 6848.0 EUR
[0708-TAB-246MZ-L] Anti-Human TNFRSF25 E. coli Rec. Antibody [Clone: 11H08_H1], Endotoxin < 1 EU/mG. - 1 mG.
Anti-Human TNFRSF25 E. coli Rec. Antibody [Clone: 11H08_H1], Endotoxin < 1 EU/mG. - 1 mG.
7,100.00 € 7100.0 EUR
[0708-TAB-246MZ] Anti-Human TNFRSF25 E. coli Rec. Antibody [Clone: 11H08_H1] - 1 mG.
Anti-Human TNFRSF25 E. coli Rec. Antibody [Clone: 11H08_H1] - 1 mG.
5,900.00 € 5900.0 EUR
[0708-TAB-337CL-1mG.] Anti-Human H5HA E. coli Rec. Antibody (CR6261) Conjug.ation: NONE Endotoxin: Regular without removal Purity: SDS-PAGE>95%, 1 mG.
Anti-Human H5HA E. coli Rec. Antibody (CR6261) Conjug.ation: NONE Endotoxin: Regular without removal Purity: SDS-PAGE>95%, 1 mG.
5,949.00 € 5949.0 EUR
  • 1
  • 2
  • 3
  • 4
  • 5

Clear Filters

Designed for research labs


The existence of sufficiently large high quality collections of reference spectra is an urgent demand of ongoing high throughput glycomics projects. The existence of an accepted depository for glyco-related spectroscopic data will guarantee that the loss of primary data can be considerably reduced.


This design study will concentrate on the development on databases for

primary carbohydrate structures and their occurrence in Nature as well as on databases for MS- and NMR-spectra and HPLC profiles.


To ensure the success of EUROCarbDB, the coordinator as well as the steering committee will follow closely the development of other glycomics database initiatives, in particular the two large glycomics projects in USA and Japan. The already existing personal interlocking of the EUROCarbDB participants (ICL, DKFZ) with the US consortium will guarantee that each project can concentrate on its own merits and specialities and maximal synergetic effects will result.

The same is true for the Japanese initiative where EUROCarbDB participants (ICL, DKFZ) are members of the advisory board. The coordinator and steering committee of EUROCarbDB will also try to come into contact with new initiatives at the earliest possible stage to avoid redundant work and to point out the standards for data representation and exchange formats developed by this consortium.

Likely expansions of EUROCarbDB at a later stage  will be the addition of experimental data like 3D-structures derived from X-ray studies, binding characteristics of carbohydrates to protein using NMR, Higher order NMR spectra (2D, 3D-spectra), Carbohydrate Microarrays, Microcalorimetry, Surface Plasmon Resonance or collections of methods for chemical, combinatorial, chemo-enzymatic and large scale synthesis of glyco-probes.


Moreover, it will advance the development of algorithms, which enable a rapid and reliable automatic  interpretation of mass spectrometry (MS) and HPLC data and nuclear magnetic resonance  (NMR) spectra.


Play with the current version of EUROCarbDB (in development!!!)


EuroCarbDB is a Research Infrastructure Design Study Funded by the 6th Research Framework Program of the European Union

(Contract: RIDS Contract number 011952)

6017 Snell Ave, Genprice, San Jose, CA 95123, United States

  • (408) 472-2934
  • info@eurocarbdb.com
Follow us
Copyright © eurocarbdb
English (UK) English (US)